GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pennant Group Inc (NAS:PNTG) » Definitions » Beneish M-Score
中文

Pennant Group (Pennant Group) Beneish M-Score

: -2.48 (As of Today)
View and export this data going back to 2019. Start your Free Trial

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.48 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Pennant Group's Beneish M-Score or its related term are showing as below:

PNTG' s Beneish M-Score Range Over the Past 10 Years
Min: -2.7   Med: -2.42   Max: -1.98
Current: -2.48

During the past 8 years, the highest Beneish M-Score of Pennant Group was -1.98. The lowest was -2.70. And the median was -2.42.


Pennant Group Beneish M-Score Historical Data

The historical data trend for Pennant Group's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pennant Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial -2.70 -2.26 -1.98 -2.42 -2.48

Pennant Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.42 -2.60 -2.43 -2.44 -2.48

Competitive Comparison

For the Medical Care Facilities subindustry, Pennant Group's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pennant Group Beneish M-Score Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Pennant Group's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Pennant Group's Beneish M-Score falls into.



Pennant Group Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Pennant Group for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9936+0.528 * 1.0063+0.404 * 1.0577+0.892 * 1.1514+0.115 * 0.9691
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9371+4.679 * -0.037021-0.327 * 0.9586
=-2.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $61.1 Mil.
Revenue was 145.954 + 140.192 + 132.281 + 126.464 = $544.9 Mil.
Gross Profit was 18.7 + 17.802 + 16.269 + 14.265 = $67.0 Mil.
Total Current Assets was $80.1 Mil.
Total Assets was $539.7 Mil.
Property, Plant and Equipment(Net PPE) was $291.5 Mil.
Depreciation, Depletion and Amortization(DDA) was $5.1 Mil.
Selling, General, & Admin. Expense(SGA) was $36.7 Mil.
Total Current Liabilities was $71.5 Mil.
Long-Term Debt & Capital Lease Obligation was $312.5 Mil.
Net Income was 4.349 + 4.383 + 2.797 + 1.85 = $13.4 Mil.
Non Operating Income was 0.245 + -0.038 + 0.032 + 0.03 = $0.3 Mil.
Cash Flow from Operations was 5.18 + 12.377 + 6.537 + 8.996 = $33.1 Mil.
Total Receivables was $53.4 Mil.
Revenue was 124.665 + 118.35 + 116.316 + 113.91 = $473.2 Mil.
Gross Profit was 16.187 + 14.279 + 14.522 + 13.598 = $58.6 Mil.
Total Current Assets was $73.8 Mil.
Total Assets was $512.1 Mil.
Property, Plant and Equipment(Net PPE) was $287.5 Mil.
Depreciation, Depletion and Amortization(DDA) was $4.9 Mil.
Selling, General, & Admin. Expense(SGA) was $34.0 Mil.
Total Current Liabilities was $70.2 Mil.
Long-Term Debt & Capital Lease Obligation was $309.9 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(61.116 / 544.891) / (53.42 / 473.241)
=0.112162 / 0.112881
=0.9936

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(58.586 / 473.241) / (67.036 / 544.891)
=0.123797 / 0.123026
=1.0063

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (80.077 + 291.521) / 539.691) / (1 - (73.822 + 287.489) / 512.119)
=0.311462 / 0.294478
=1.0577

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=544.891 / 473.241
=1.1514

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(4.9 / (4.9 + 287.489)) / (5.13 / (5.13 + 291.521))
=0.016758 / 0.017293
=0.9691

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(36.667 / 544.891) / (33.981 / 473.241)
=0.067292 / 0.071805
=0.9371

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((312.51 + 71.549) / 539.691) / ((309.934 + 70.247) / 512.119)
=0.711628 / 0.742368
=0.9586

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(13.379 - 0.269 - 33.09) / 539.691
=-0.037021

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Pennant Group has a M-score of -2.48 suggests that the company is unlikely to be a manipulator.


Pennant Group Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Pennant Group's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Pennant Group (Pennant Group) Business Description

Traded in Other Exchanges
Address
1675 East Riverside Drive, Suite 150, Eagle, ID, USA, 83616
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health and hospice services which includes our home health, hospice, and home care businesses and Senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Iowa, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The majority of the revenue is generated from the Home Health and Hospice Services segment.
Executives
Jennifer Freeman officer: Chief Financial Officer C/O THE PENNANT GROUP, INC., 1675 E. RIVERSIDE DRIVE, SUITE 120, EAGLE ID 83616
Lynette Walbom officer: Chief Financial Officer 1675 E. RIVERSIDE DR., SUITE 150, EAGLE ID 83616
John J Gochnour officer: Chief Operating Officer C/O THE PENNANT GROUP, INC., 1675 E. RIVERSIDE DRIVE, SUITE 100, EAGLE ID 83616
Joanne Stringfield director C/O THE PENNANT GROUP, INC., 1675 E. RIVERSIDE DRIVE, SUITE 120, EAGLE ID 83616
Barry M Smith director 4800 N SCOTTSDALE RD, SUITE 5000, SCOTTSDALE AZ 85251
John G. Nackel director 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Christopher R. Christensen director 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Morris Gregory K Sr. director 1675 E RIVERSIDE DR, SUITE 150, EAGLE ID 83616
Daniel H Walker director, officer: See Remarks C/O THE PENNANT GROUP, INC., 1675 E. RIVERSIDE DRIVE, STE 150, EAGLE ID 83616
Brent Guerisoli officer: President 1675 E RIVERSIDE DR, SUITE 150, EAGLE ID 83616
Derek J Bunker officer: See Remarks C/O THE PENNANT GROUP, INC., 1675 E. RIVERSIDE DRIVE, STE 150, EAGLE ID 83616
Scott E Lamb director ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Roderic W Lewis director
Covey Stephen M R director
Ensign Group, Inc 10 percent owner 29222 RANCHO VIEJO RD., SUITE 127, SAN JUAN CAPISTRANO CA 92675

Pennant Group (Pennant Group) Headlines

From GuruFocus

Pennant Announces Second Quarter 2022 Earnings Release and Call

By PurpleRose PurpleRose 08-04-2022

Pennant Announces Third Quarter 2022 Earnings Release and Call

By Value_Insider Value_Insider 11-03-2022

The Pennant Group Announces Share Repurchase Program

By Value_Insider Value_Insider 12-13-2022

Pennant Announces First Quarter 2023 Earnings Release and Call

By sperokesalga sperokesalga 04-21-2023

Pennant Acquires California Hospice and Home Health Provider

By PurpleRose PurpleRose 08-16-2022

Pennant Announces New Leadership Structure

By GuruFocusNews GuruFocusNews 07-07-2022